Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome

SJ Aronson; P Veron; F Collaud; A Hubert; V Delahais; G Honnet; Rob de Knegt; N Junge; U Baumann; A Di Giorgio; L D'Antiga; VM Ginocchio; N Brunetti-Pierri; P Labrune; U Beuers; PJ Bosma; F Mingozzi

doi:10.1089/hum.2019.143

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome

SJ Aronson, P Veron, F Collaud, A Hubert, V Delahais, G Honnet, Rob de Knegt, N Junge, U Baumann, A Di Giorgio, L D'Antiga, VM Ginocchio, N Brunetti-Pierri, P Labrune, U Beuers, PJ Bosma, F Mingozzi

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

1 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1297-1305
Number of pages	9
Journal	Human Gene Therapy
Volume	30
Issue number	10
DOIs	https://doi.org/10.1089/hum.2019.143
Publication status	Published - 2019

Access to Document

10.1089/hum.2019.143

Repub_120114_O-A.pdfFinal published version, 265 KB

http://hdl.handle.net/1765/120114

Cite this

Aronson, SJ., Veron, P., Collaud, F., Hubert, A., Delahais, V., Honnet, G., de Knegt, R., Junge, N., Baumann, U., Di Giorgio, A., D'Antiga, L., Ginocchio, VM., Brunetti-Pierri, N., Labrune, P., Beuers, U., Bosma, PJ., & Mingozzi, F. (2019). Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome. Human Gene Therapy, 30(10), 1297-1305. https://doi.org/10.1089/hum.2019.143

Aronson, SJ ; Veron, P ; Collaud, F ; Hubert, A ; Delahais, V ; Honnet, G ; de Knegt, Rob ; Junge, N ; Baumann, U ; Di Giorgio, A ; D'Antiga, L ; Ginocchio, VM ; Brunetti-Pierri, N ; Labrune, P ; Beuers, U ; Bosma, PJ ; Mingozzi, F. / Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome. In: Human Gene Therapy. 2019 ; Vol. 30, No. 10. pp. 1297-1305.

@article{0fcbcf9a1ff6457985f4b6334d9e57ce,

title = "Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome",

author = "SJ Aronson and P Veron and F Collaud and A Hubert and V Delahais and G Honnet and {de Knegt}, Rob and N Junge and U Baumann and {Di Giorgio}, A and L D'Antiga and VM Ginocchio and N Brunetti-Pierri and P Labrune and U Beuers and PJ Bosma and F Mingozzi",

year = "2019",

doi = "10.1089/hum.2019.143",

language = "Undefined/Unknown",

volume = "30",

pages = "1297--1305",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "10",

}

Aronson, SJ, Veron, P, Collaud, F, Hubert, A, Delahais, V, Honnet, G, de Knegt, R, Junge, N, Baumann, U, Di Giorgio, A, D'Antiga, L, Ginocchio, VM, Brunetti-Pierri, N, Labrune, P, Beuers, U, Bosma, PJ & Mingozzi, F 2019, 'Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome', Human Gene Therapy, vol. 30, no. 10, pp. 1297-1305. https://doi.org/10.1089/hum.2019.143

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome. / Aronson, SJ; Veron, P; Collaud, F; Hubert, A; Delahais, V; Honnet, G; de Knegt, Rob; Junge, N; Baumann, U; Di Giorgio, A; D'Antiga, L; Ginocchio, VM; Brunetti-Pierri, N; Labrune, P; Beuers, U; Bosma, PJ; Mingozzi, F.

In: Human Gene Therapy, Vol. 30, No. 10, 2019, p. 1297-1305.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome

AU - Aronson, SJ

AU - Veron, P

AU - Collaud, F

AU - Hubert, A

AU - Delahais, V

AU - Honnet, G

AU - de Knegt, Rob

AU - Junge, N

AU - Baumann, U

AU - Di Giorgio, A

AU - D'Antiga, L

AU - Ginocchio, VM

AU - Brunetti-Pierri, N

AU - Labrune, P

AU - Beuers, U

AU - Bosma, PJ

AU - Mingozzi, F

PY - 2019

Y1 - 2019

U2 - 10.1089/hum.2019.143

DO - 10.1089/hum.2019.143

M3 - Article

VL - 30

SP - 1297

EP - 1305

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 10

ER -